Giant prolactinomas presenting as skull base tumors
Authors:
- Giuseppe MinnitiGiuseppe Minniti
- Marie-Lise Jaffrain-ReaMJMarie-Lise Jaffrain-Rea
- Antonio SantoroASAntonio Santoro
- Vincenzo EspositoVEVincenzo Esposito
- Luigi FerranteLFLuigi Ferrante
- Roberto DelfiniRDRoberto Delfini
- Giampaolo CantoreGCGiampaolo Cantore
- 1 February 2002
- journal article
- case report
- Published by Elsevier in Surgical Neurology
- Vol. 57 (2) , 99-103
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomasClinical Endocrinology, 2000
- Usefulness of markers of cell proliferation in the management of pituitary adenomasClinical Science, 1998
- Late Development of Resistance to Bromocriptine in a Patient with MacroprolactinomaHormone Research in Paediatrics, 1998
- Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptineEuropean Journal of Endocrinology, 1996
- Prolactinomas in men masquerading as invasive skull base tumoursBritish Journal Of Neurosurgery, 1994
- Dopamine Agonists and Pituitary Tumor ShrinkageEndocrine Reviews, 1992
- Should dopamine agonist treatment for prolactinomas be life-long?Clinical Endocrinology, 1991
- Subarachnoid dissemination of a pituitary adenomaSurgical Neurology, 1987
- Long-Lasting Prolactin-Lowering Effect of Cabergoline, A New Dopamine Agonist, in Hyperprolactinemic PatientsThe Journal of Clinical Endocrinology & Metabolism, 1986
- Low Doses of Dopamine Agonists in the Long-Term Treatment of MacroprolactinomasNew England Journal of Medicine, 1985